10/15/2024 5:00 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 5:00 PM | CRISPR Therapeutics (Issuer) KASINGER JAMES R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 5:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 4:22 PM | CRISPR Therapeutics (Filer)
| Form S-3ASR | |
06/24/2024 4:35 PM | Bruno Julianne (Reporting) CRISPR Therapeutics (Issuer) CRISPR Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 7:06 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2024 3:50 PM | Behbahani Ali (Reporting) CRISPR Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/31/2024 3:50 PM | CRISPR Therapeutics (Issuer) George Simeon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 7:14 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 3:15 PM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/17/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2024 3:24 PM | CRISPR Therapeutics (Subject) Kulkarni Samarth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 10:58 AM | Capital International Investors (Filed by) CRISPR Therapeutics (Subject)
| Form SC 13G/A | |
04/09/2024 3:42 PM | CRISPR Therapeutics (Filer)
| Form DEF 14A | |
04/09/2024 3:43 PM | CRISPR Therapeutics (Filer)
| Form DEFA14A | |
04/09/2024 3:47 PM | CRISPR Therapeutics (Filer)
| Form ARS | |
03/27/2024 3:30 PM | CRISPR Therapeutics (Filer)
| Form PRE 14A | |
03/27/2024 3:30 PM | CRISPR Therapeutics (Filer)
| Form PRE 14A | |
03/22/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:45 PM | CRISPR Therapeutics (Issuer) Prasad Raju (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:45 PM | CRISPR Therapeutics (Issuer) KASINGER JAMES R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:02 PM | CRISPR Therapeutics (Subject) Morrow Phuong Khanh (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 4:45 PM | CRISPR Therapeutics (Issuer) Prasad Raju (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:43 PM | CRISPR Therapeutics (Subject) Kulkarni Samarth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 4:45 PM | CRISPR Therapeutics (Issuer) KASINGER JAMES R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:39 PM | CRISPR Therapeutics (Issuer) George Simeon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 4:45 PM | CRISPR Therapeutics (Issuer) KASINGER JAMES R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 6:45 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 6:50 AM | CRISPR Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/16/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:30 PM | CRISPR Therapeutics (Subject) Kulkarni Samarth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 4:22 PM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 7:44 AM | CRISPR Therapeutics (Filer)
| Form 424B5 | |
02/13/2024 5:30 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 5:30 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 5:22 PM | CRISPR Therapeutics (Subject) Nikko Asset Management Americas, Inc. (Filed by)
| Form SC 13G/A | |
02/05/2024 5:08 AM | CRISPR Therapeutics (Subject) Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
| Form SC 13G/A | |
01/31/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
A Totally New ‘Income Coin’ (Ad) Buckle up…
Because this might shatter everything you thought you knew about "income trading."
In fact, it's such a radical departure from what most people think of when it comes to typical income strategies, I'm calling it:
The Perfect Income Altcoin Click here to get access to my 'Perfect Income Altcoin' for just $3 today. |
01/29/2024 3:00 PM | ARK Investment Management LLC (Filed by) CRISPR Therapeutics (Subject)
| Form SC 13G/A | |
01/18/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 10:36 AM | ARK Investment Management LLC (Filed by) CRISPR Therapeutics (Subject)
| Form SC 13G/A | |
12/15/2023 7:58 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/13/2023 8:22 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 12:16 PM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/16/2023 6:21 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 3:42 PM | CRISPR Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023 3:33 PM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2023 4:52 PM | CRISPR Therapeutics (Issuer) Morrow Phuong Khanh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 4:52 PM | CRISPR Therapeutics (Issuer) Prasad Raju (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 4:48 PM | CRISPR Therapeutics (Issuer) KASINGER JAMES R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 4:51 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |